The Patent Finder

Cocrystal Pharma, Inc.

Also on record
Records under this name other than the patents Cocrystal Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Back to Cocrystal Pharma, Inc.

PatentTitleStatus Expires Confidence
US 8,415,321Nucleoside Derivatives for Treatment of Caliciviridae Infections, Including Norovirus Infections
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,181,227Potent and Selective Inhibitors of Hepatitis C Virus
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,926,295Potent and Selective Inhibitors of Hepatitis C Virus
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,809,616Pyrimidine Nucleosides and Their Monophosphate Prodrugs for Treatment of Viral Infections and Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,011,629Nucleoside Analogs for Treatment of the Flaviviridae Family of Viruses and Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,932,326Potent and Selective Inhibitors of Hepatitis C Virus
Formerly held
Lapsed on the fee record
Ended Apr 3, 2026 · High confidence
Lapsed on the fee recordEnded Apr 3, 2026High confidence
US 9,707,215Inhibitors of hepatitis C virus polymerase
Lapsed on the fee record
Ended Jul 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 18, 2025From the USPTO record
US 10,947,210Inhibitors of Hepatitis C virus polymerase
Lapsed on the fee record
Ended Mar 16, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 16, 2025From the USPTO record
US 10,426,762Inhibitors of hepatitis C virus polymerase
Lapsed on the fee record
Ended Oct 1, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 1, 2023From the USPTO record
US 8,895,5312′-fluoronucleoside phosphonates as antiviral agents
Lapsed on the fee record
Ended Nov 25, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 25, 2022From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited